Flagship-Backed Generate Biomedicines Raises $400 Million in IPO
Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range....
Redirecting to full article...
Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range....
Redirecting to full article...